Skip to main content
. 2012 Oct 24;15(1):78–84. doi: 10.1111/j.1477-2574.2012.00594.x

Figure 2.

Figure 2

Survival curves according to the portal hypertension (PHTN) and biochemical parameters: (a) Barcelona Clinic Liver Cancer (BCLC) A1 class (no-PHTN) versus BCLC A2 class (PHTN and normal bilirubin) versus BCLC A3 class (PHTN and abnormal bilirubin); (b) no-PHTN vesus PHTN and normal albumin versus PHTN and abnormal albumin; (c) no-PHTN versus PHTN and normal international normalized ratio (INR) versus PHTN and an abnormal INR